Novel test identifies patients most likely to benefit from ALK inhibition therapy

Economical, easy to perform compared to existing tests, reported in The Journal of Molecular Diagnostics

2012-12-12

(Press-News.org) Philadelphia, PA, December 12, 2012 – Approximately one in 20 patients with non-small cell lung carcinoma (NSCLC) has chromosomal aberrations targeting the anaplastic lymphoma kinase (ALK) gene. This has considerable implications for treatment because these patients are highly responsive to ALK-specific kinase inhibitors such as crizotinib. However, current diagnostic tests have limitations. Researchers have now developed and tested a promising new method for screening ALK fusions in NSCLC. This new diagnostic assay offers a cost-effective and easy-to-perform alternative to existing tests. The study is published in The Journal of Molecular Diagnostics.

Crizotinib is a protein tyrosine kinase inhibitor approved by the FDA for the treatment of locally advanced or metastatic ALK-positive NSCLC as detected by an FDA-approved test and is undergoing phase III clinical trials. It is crucial to the clinical success of ALK inhibitors to identify those patients most likely to benefit from ALK inhibition. The latest National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology now recommend upfront ALK screening for all patients with NSCLC.

There are several clinically validated methodologies currently available for the detection of ALK fusions, including fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and reverse transcription-polymerase chain reaction (RT-PCR). Crizotinib-centered clinical trials currently utilize a FISH-based test that was recently approved by FDA as the standard companion diagnostic test for crizotinib. However, it is complex and has considerable limitations in terms of cost and throughput, making it difficult to screen large numbers of patients.

"The FISH assay has undergone extensive validation in clinical setting and is currently the gold standard for ALK fusion detection," say lead investigators Dong-Wan Kim, MD, PhD, Seoul National University Hospital, Seoul, South Korea, and Mao Mao, MD, PhD, Pfizer Oncology, California. "A disadvantage of this diagnostic assay, however, lies in the fact that the signal can be subtle and consequently hard to interpret, requiring specialized technical expertise. It is also considerably more expensive compared with IHC and RT-PCR."

In the early phase trial of crizotinib, approximately 1500 patients were screened by FISH to identify 82 ALK-positive patients. The large number of patients qualifying for screening underscores the need for a high throughput and cost- effective screening modality. "An optimal assay should therefore not only be sensitive and specific, but also be economical, easy to perform, preferably automated, and readily adaptable to workflows of clinical service laboratories," continue the investigators.

To explore alternative screening modalities for detecting ALK fusions, they designed a novel method for detecting ALK fusions by direct, multiplexed transcript profiling using the gene expression platform from NanoString. They tested their assay in 66 archival NSCLC samples which had been independently tested by both FISH and IHC methods in terms of sensitivity, specificity, reproducibility, and concordance to prior FISH and IHC.

The results were highly concordant to previous results obtained by FISH and IHC and the investigators were able to successfully detect low-level ALK fusion transcripts in samples with low tumor cell content. All samples predicted to be positive in the assay responded favorably to crizotinib.

"While further testing on a larger sample size is needed for this assay to be considered in clinical practice, we have demonstrated that it offers a cost-effective, easy to perform, high-throughput, and FFPE-compatible screening alternative for detecting ALK fusions," conclude the investigators. ### END

ELSE PRESS RELEASES FROM THIS DATE:

Frog-in-bucket-of-milk folklore leads to potential new antibiotics

2012-12-12

Following up on an ancient Russian way of keeping milk from going sour — by putting a frog in the bucket of milk — scientists have identified a wealth of new antibiotic substances in the skin of the Russian Brown frog. The study appears in ACS' Journal of Proteome Research. A. T. Lebedev and colleagues explain that amphibians secrete antimicrobial substances called peptides through their skin. These compounds make up the majority of their skin secretions and act as a first line of defense against bacteria and other microorganisms that thrive in the wet places frogs, toads, ...

A promising clinical trial to reduce the severity of autistic disorders

2012-12-12

This press release is available in French. Although this therapy is not curative, it nevertheless reduced the autistic disorders' severity in three-quarters of the children. The researchers have filed a request for authorisation to perform a multi-centre European clinical trial in order to determine more precisely the population concerned by this therapy. Details of this work have been published in the Translational Psychiatry review dated 11 December 2012. Contribution made by the fundamental research on neuronal chloride Previous work carried out by the team of ...

New twist on using biomass for perfume, cosmetic, personal care products

2012-12-12

In a new approach for tapping biomass as a sustainable raw material, scientists are reporting use of a Nobel-Prize-winning technology to transform plant "essential oils" — substances with the characteristic fragrance of the plant — into high-value ingredients for sunscreens, perfumes and other personal care products. The report on the approach, which could open up new economic opportunities for tropical countries that grow such plants, appears in the Journal of the American Chemical Society. Deryn Fogg, Eduardo dos Santos and colleagues explain that breaking down plant ...

New geometries: Researchers create new shapes of artificial microcompartments

2012-12-12

In nature, biological functions are often carried out in tiny protective shells known as microcompartments, structures that provide home to enzymes that convert carbon dioxide into energy in plant cells and to viruses that replicate once they enter the cell. Most of these shells buckle into an icosahedron shape, forming 20 sides that allow for high interface with their surroundings. But some shells — such as those found in the single-celled Archaea or simple, salt-loving organisms called halophiles —break into triangles, squares, or non-symmetrical geometries. While these ...

Scientists train honey bees to stick out their tongues

2012-12-12

Honey bees are a highly organized, social species, as demonstrated by their complex colonies and the geometric structure of their hives. For hive building, the honey bee strongly relies on its tactile sense, and a new video-article in JoVE (Journal of Visualized Experiments) illustrates a novel tactile conditioning experiment using honey bees. The technique, presented by the lab of Dr. Volker Dürr of Bielefeld University, trains honey bees to stick out their tongues when their antennae touch an object. This procedure allows researchers to analyze how changes in antennal ...

A second ascent of chemistry's Mt. Everest

2012-12-12

In science's equivalent of ascending Mt. Everest, researchers are reporting success in one of the most difficult challenges in synthetic chemistry — a field in which scientists reproduce natural and other substances from jars of chemicals in a lab. The feat, reported in the Journal of the American Chemical Society, involved synthesis of a rare substance with promising in vitro anti-cancer effects found naturally in tiny amounts in a Chinese medicinal herb. Samuel J. Danishefsky and Feng Peng explain that maoecrystal V occurs naturally in a plant growing in China's Yunnan ...

Will climate change cause water conflict?

2012-12-12

International researchers from 14 institutions met in Nicosia (Cyprus) on the 10th and 11th of December to present and debate the results of studies on water, conflict and security conducted in the past three years in a variety of locations in the Mediterranean, Middle East and Sahel under the CLICO research project. The CLICO project explored the social dimensions of climate change and in particular, conflicts related to water, and the threats this may pose for national and human security. The project was led by the Institute for Environmental Science and Technology (ICTA) ...

Relocating elephants fails to decrease human–wildlife conflict

2012-12-12

Human–elephant conflict in Sri Lanka kills more than 70 humans and 200 Asian elephants every year. One of the most common tools in combating these conflicts is moving the elephants into ranges away from humans, often into national parks. This is done in hopes of avoiding problems that include elephants raiding crops, breaking into homes and injuring or killing people. But according to a new study to be published Dec. 7 in PLOS ONE by the Smithsonian Conservation Biology Institute, the Centre for Conservation and Research in Sri Lanka and the Department of Wildlife Conservation ...

Cane toads can be stopped

2012-12-12

It may be possible to stop the spread of can toads into new areas of Australia according to new research published today in the Journal of Applied Ecology. One of the lead authors of the study, James Cook University's Dr Ben Phillips, said that their work, which involved an international team of scientists, showed that artificial waterbodies installed by graziers acted as critical stepping-stones for the toad invasion. "By removing these waterbodies in key locations it is possible to halt the spread of toads," he said. Cane toads are currently spreading into the vast ...

Emerging virus in raccoons may provide cancer clues

2012-12-12

Rare brain tumors emerging among raccoons in Northern California and Oregon may be linked to a previously unidentified virus discovered by a team of researchers, led by scientists from the University of California, Davis. Their findings, published today in the journal Emerging Infectious Diseases, could lead to a better understanding of how viruses can cause cancer in animals and humans. Necropsies conducted since March 2010 by scientists at the UC Davis School of Veterinary Medicine and UC Davis-led California Animal Health and Food Safety Laboratory found brain tumors ...

Novel test identifies patients most likely to benefit from ALK inhibition therapy

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: